Soleno Therapeutics, Inc.(SLNO)
Pharmaceuticals
Specialty Pharma
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Huang Michael F. Sr. VP of Clinical Development | Sale | -6,582 | -14.18%39,823 | $30.44 | $200,365 | View SEC filing | |
| 2026-03-31 | Manning Meredith Chief Commercial Officer | Sale | -7,522 | -37.89%12,328 | $30.44 | $228,980 | View SEC filing | |
| 2025-07-03 | Hirano Patricia C SEE REMARKS | Sale | -3,830 | -5.75%62,775 | $82.76 | $316,971 | View SEC filing | |
| 2025-06-26 | Hirano Patricia C SEE REMARKS | Sale | -266 | -0.40%66,605 | $84.25 | $22,411 | View SEC filing | |
| 2025-04-02 | Hirano Patricia C SEE REMARKS | Sale | -3,782 | -12.27%27,036 | $70.11 | $265,156 | View SEC filing | |
| 2025-03-31 | Pauls Matthew Director | Sale | -5,937 | -47.74%6,500 | $71.55 | $424,797 | View SEC filing | |
| 2025-03-31 | Yen Kristen SEE REMARKS | Sale | -95,500 | -59.12%66,024 | $66.77 | $6,376,789 | View SEC filing | |
| 2025-03-31 | Manning Meredith Chief Commercial Officer | Sale | -45,249 | -35.46%82,351 | $67.28 | $3,044,343 | View SEC filing | |
| 2025-03-31 | Mackaness James H CHIEF FINANCIAL OFFICER | Sale | -90,622 | -41.99%125,176 | $69.44 | $6,293,177 | View SEC filing | |
| 2025-03-31 | Huang Michael F. Sr. VP of Clinical Development | Sale | -14,583 | -23.75%46,817 | $69.51 | $1,013,627 | View SEC filing | |
| 2025-03-31 | Hirano Patricia C SEE REMARKS | Sale | -156,315 | -83.53%30,818 | $68.51 | $10,709,353 | View SEC filing | |
| 2025-03-31 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | Sale | -699,095 | -53.66%603,682 | $67.62 | $47,271,960 | View SEC filing | |
| 2025-03-28 | Vivo Opportunity, LLC 10% Owner | Sale | -1,833,557 | -29.14%4,458,294 | $67.87 | $124,449,124 | View SEC filing | |
| 2025-01-06 | Yen Kristen SEE REMARKS | Sale | -4,860 | -5.97%76,605 | $45.78 | $222,484 | View SEC filing | |
| 2025-01-06 | Mackaness James H CHIEF FINANCIAL OFFICER | Sale | -7,874 | -6.61%111,298 | $45.78 | $360,460 | View SEC filing | |
| 2025-01-06 | Hirano Patricia C SEE REMARKS | Sale | -3,030 | -2.78%105,902 | $45.78 | $138,709 | View SEC filing | |
| 2025-01-06 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | Sale | -21,091 | -2.93%698,462 | $45.78 | $965,516 | View SEC filing | |
| 2024-10-03 | Yen Kristen SEE REMARKS | Sale | -3,108 | -3.67%81,465 | $49.43 | $153,627 | View SEC filing | |
| 2024-10-03 | Mackaness James H CHIEF FINANCIAL OFFICER | Sale | -8,077 | -6.35%119,172 | $49.43 | $399,241 | View SEC filing | |
| 2024-10-03 | Hirano Patricia C SEE REMARKS | Sale | -3,108 | -2.77%108,932 | $49.43 | $153,627 | View SEC filing | |
| 2024-10-03 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | Sale | -21,633 | -2.92%719,553 | $49.43 | $1,069,306 | View SEC filing | |
| 2024-08-30 | Yen Kristen SEE REMARKS | Sale | -10,705 | -11.24%84,573 | $47.43 | $507,745 | View SEC filing | |
| 2024-08-30 | Mackaness James H CHIEF FINANCIAL OFFICER | Sale | -13,531 | -9.61%127,249 | $47.43 | $641,783 | View SEC filing | |
| 2024-08-30 | Hirano Patricia C SEE REMARKS | Sale | -10,705 | -8.72%112,040 | $47.43 | $507,745 | View SEC filing | |
| 2024-08-30 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | Sale | -115,004 | -13.43%741,186 | $47.43 | $5,454,707 | View SEC filing |
1-25 of 132
Page 1 of 6